Normal tension glaucoma;Glaucoma de pressão normal

Arquivos Brasileiros de Oftalmologia

Volumn 68, Issue 4, 2005, Pages 565-575

  Tavares, Ivan Maynart ^a,b,c   De Arruda Mello, Paulo Augusto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CAPES MEC   (Brazil)

Author keywords

Diagnosis, differential; Diagnostic techniques, ophthalmological; Glaucoma, open angle; Glaucoma complications; Glaucoma diagnosis; Glaucoma physiopathology; Glaucoma therapy; Review publication type ; Tonometry, ocular methods

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; VISUAL FIELD;

EID: 29244480938     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492005000400028     Document Type: Article

References (125)

1. Bankes JL, Perkins ES, Tsolakis S, Wright JE. Bedford glaucoma survey. Br Med J. 1968;1(595):791-6.
2. Shiose Y, Komuro K, Itoh T, Amano M, Kawase Y. New system for mass screening of glaucoma as part of automated multiphasic health testing services. Jpn J Ophthalmol. 1981:25(1):106-77.
3. Sakata K, Scapucin L, Sakata LM, Carvalho ACA, Selonke I, Sakata VM, et al. Projeto glaucoma: resultados parciais 2000 na região de Piraquara-PR. Arq Bras Oftalmol. 2002;65(3):333-7.
4. th ed. Baltimore: Williams & Wilkins; 1998.
5. nd ed. New York: Mosby; 1995.
6. Fechtner RD, Realini T. Normal-tension glaucoma [monography on the Internet]. San Francisco: American Academy of Ophthalmology; 2004. [citado 2004 Jun 10]. Available from: http://www.aao.org/education/courses/ntg/index.cfm
7. Buono LM, Foroozan R, Sergott RC, Savino PJ. Is normal tension glaucoma actually an unrecognized hereditary optic neuropathy? New evidence from genetic analysis. Curr Opin Ophthalmol. 2002;13(6):362-70.
8. Quigley HA. New paradigms in the mechanisms and management of glaucoma. Eye [serial on the Internet]. 2004 Oct. [cited 2004 Dez 17]. DOI:10.1038. Available from: http://www.nature.com/eye/journal/vaop/ncurrent/full/6701746a. html
9. Gramer E, Leydhecker W. [Glaucoma without ocular hypertension. A clinical study]. Klin Monatsbl Augenheilkd. 1985;186(4):262-7. German.
10. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126(4):487-97.
11. Erratum in: Am J Ophthalmol 1999;127(1):120.
12. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126(4):498-505.
13. Anderson DR, Drance SM, Schulzer M: Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108(2):247-53.
14. Tavares IM, Melo Jr LAS, Fasolo LR, Moura CR, Prata Jr JA, Schor R, et al. Estudo do Glaucoma de Pressão Normal (CNTGS) e Estudo do Tratamento da Hipertensão Ocular (OHTS). In: Paranhos Jr A, Mello PAA, Reys JC, editores. Atualidades: grandes ensaios clínicos em glaucoma. São Paulo: Lemos; 2003. p.8-13.
15. Sommer A. Collaborative normal-tension glaucoma study. Am J Ophthalmol. 1999;128(6):776-7.
16. Sycha T, Vass C, Findl O, Bauer P, Groke I, Schmetterer L, et al. Interventions for normal tension glaucoma. Cochrane Database Syst Rev. 2003(4): CD002222.
17. Caprioli J. The treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):578-81.
18. Krupin T, Liebmann JM, Greenfield DS, Rosenberg LF, Ritch R, Yang JW. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients. Ophthalmology. 2005;112(3):376-85.
19. Stroman GA, Stewart WC, Golnik KC, Cure JK, Olinger RE. Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol. 1995;113(2):168-72.
20. Drance S, Anderson DR, Schulzer M: Collaborative Normal-tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131(6): 699-708.
21. Kim SJ, Park KH. Four cases of normal-tension glaucoma with disk hemorrhage combined with branch retinal vein occlusion in the contralateral eye. Am J Ophthalmol. 2004;137(2):357-9.
22. Vetrugno M, Cicco G, Cantatore F, Arnese L, Delle Noci N, Sborgia C. Red blood cell deformability, aggregability and cytosolic calcium concentration in normal tension glaucoma. Clin Hemorheol Microcirc. 2004;31(4):295-302.
23. Akar ME, Taskin O, Yucel I, Akar Y. The effect of the menstrual cycle on optic nerve head analysis in healthy women. Acta Ophthalmol Scand. 2004; 82(6):741-5.
24. Akar Y, Yucel I, Akar ME, Taskin O, Ozer HO. Menstrual cycle-dependent changes in visual field analysis of healthy women. Ophthalmologica. 2005; 219(1):30-5.
25. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause. 2004;11(1):69-77.
26. Toda Y, Tang S, Kashiwagi K, Mabuchi F, Iijima H, Tsukahara S, et al. Mutations in the optineurin gene in Japanese patients with primary open-angle glaucoma and normal tension glaucoma. Am J Med Genet. 2004; 125(1):1-4.
27. Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N. Complex autoantibody repertoires in patients with glaucoma. Mol Vis. 2004;10:132-7.
28. Tomita G. The optic nerve head in normal-tension glaucoma. Curr Opin Ophthalmol. 2000;11(2):116-20.
29. Fuse N, Takahashi K, Akiyama H, Nakazawa T, Seimiya M, Kuwahara S, et al. Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population. J Glaucoma. 2004; 13(4):299-303.
30. Sarfarazi M, Child A, Stoilova D, Brice G, Desai T, Trifan OC, et al. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet. 1998;62(3):641-52.
31. Kremmer S, Kreuzfelder E, Bachor E, Jahnke K, Selbach JM, Seidahmadi S. Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies. Br J Ophthalmol. 2004; 88(10):1259-62.
32. Bachor E, Kremmer S, Kreuzfelder E, Jahnke K, Seidahmadi S. Antiphospholipid antibodies in patients with sensorineural hearing loss. EmArch Otorhinolaryngol [serial on the Internet]. 2005 Feb; DOI: 10.1007/s00405-004- 0877-y. Available from: http://www.springerlink.com/media/6EA5QHQRUQD2M1VN8Q9X/ Contributions/7/G/7/8/7G78FBGEBBTNN WDG_html/fulltext.html
33. Shiose Y, Kitazawa Y, Tsukahara S, Akamatsu T, Mizokami K, Futa R, et al. Epidemiology of glaucoma in Japan - a nationwide glaucoma survey. Jpn J Ophthalmol. 1991;35(2):133-55.
34. Kent A. Low-tension glaucoma. In: Higginbotham E, Lee D, editors. Clinical guide to glaucoma management. Woburn: Elsevier; 2004. p. 183.
35. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6):714-20: discussion 829-30.
36. Sakata K, Selonke I, Schmitt A, Garndinetti A, Sakata V, Guerra DR, et al. Glaucoma de pressão normal e espessura corneana central. Arq Bras Oftalmol. 2002;65(6):619-22.
37. Dave H, Kutschan A, Pauer A, Wiegand W. [Measurement of corneal thickness in glaucoma patients]. Ophthalmologe. 2004;101(9):919-24. German.
38. Meirelles SHS, Stohler NSF, Mariano MP, Yamane R, Yamane Y. Espessura comeana no glaucoma de pressão normal. Rev Bras Oftalmol. 2001;60(1):56-64.
39. Wu LL, Suzuki Y, Ideta R, Araie M. Central comeal thickness of normal tension glaucoma patients in Japan. Jpn J Ophthalmol. 2000;44(6):643-7.
40. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001; 108(10):1779-88.
41. Shah S, Chatterjee A, Mathai M, Kelly SP, Kwartz J, Henson D, et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology. 1999;106(11):2154-60.
42. Morad Y, Sharon E, Hefetz L, Nemet P. Corneal thickness and curvature in normal-tension glaucoma. Am J Ophthalmol. 1998;125(2):164-8.
43. Brandt JD. Corneal thickness in glaucoma screening, diagnosis, and management. Curr Opin Ophthalmol. 2004;15(2):85-9.
44. Paranhos Jr A, Paranhos FR, Prata Jr JA, Omi CA, Mello PA, Shields MB. Influence of keratometric readings on comparative intraocular pressure measurements with Goldmann. Tono-Pen, and noncontact tonometers. J Glaucoma. 2000;9(3):219-23.
45. La Rosa FA, Gross RL, Orengo-Nania S. Central comeal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations. Arch Ophthalmol. 2001;119(1):23-7.
46. Nemesure B, Wu SY, Hennis A, Leske MC; Barbados Eye Study Group. Corneal thickness and intraocular pressure in the Barbados eye studies. Arch Ophthalmol. 2003;121(2):240-4.
47. Calixto N, Meira DM, Cronemberger S. Estudo de pacientes com suspeita diagnóstica glaucoma de pressão normal. Rev Bras Oftalmol. 1997;56(11): 823-34.
48. Sakata L, Busato D, Gonzalez EW, Mucke D, Sakata V, Sakata K. Curva tensional diária no glaucoma de pressão normal - análise de 39 casos. Rev Bras Oftalmol. 2003;62(4):259-65.
49. Araújo MC, Katayama ME, Fontes M, Yamane R. Reprodutividade e perfil da minicurva da pressão intra-ocular em um hospital universitário. Rev Bras Oftalmol. 2001;60(6):402-9.
50. Tavares IM, Melo Jr LAS, Motta MM, Higa FS, Mello PA, Paranhos Jr A. Tonometria de não-contato: variação com medidas repetidas com e sem colírio anestésico. Arq Bras Oftalmol. 2003;66(6):835-8.
51. Caprioli J, Spaeth GL. Comparison of the optic nerve head in high- and low-tension glaucoma. Arch Ophthalmol. 1985;103(8):1145-9.
52. Eid TE, Spaeth GL, Moster MR, Augsburger JJ. Quantitative differences between the optic nerve head and peripapillary retina in low-tension and high-tension primary open-angle glaucoma. Am J Ophthalmol. 1997;124(6):805-13.
53. Kiriyama N, Ando A, Fukui C, Nambu H, Nishikawa M, Terauchi H, et al. A comparison of optic disc topographic parameters in patients with primary open angle glaucoma, normal tension glaucoma, and ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2003;241(7):541-5.
54. Borges KF. Análise esteriométrica do disco óptico com Heildelberg Retina Tomograph (HRT) em pacientes com Glaucoma de Tensão Normal (GNT). Rev Bras Oftalmol. 1999;58(6):459-62.
55. Ahn JK, Kang JH, Park KH. Correlation between a disc hemorrhage and peripapillary atrophy in glaucoma patients with a unilateral disc hemorrhage. J Glaucoma. 2004;13(1):9-14.
56. Susanna Junior R, Nicolela MT, Fontes MLM. Atrofia peripapilar em glaucoma de pressão normal, de pressão normal, de pressão elevada e em hipertensos oculares e sua importância clínica. Rev Bras Oftalmol. 1992;51(6):365-70.
57. Park KH, Park SJ, Lee YJ, Kim JY, Caprioli J. Ability of peripapillary atrophy parameters to differentiate normal-tension glaucoma from glaucomalike disk. J Glaucoma. 2001;10(2):95-101.
58. Borges KF. Análise com Heidelberg Retina Tomograph da espessura da camada de fibras nervosas retinianas e do volume de escavação papilar em zonas alfa e beta de atrofia para-papilar em pacientes glaucomatosos. Rev Bras Oftalmol. 2000;59(3):204-8.
59. Anderson DR: Normal Tension Glaucoma Study. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003;14(2):86-90.
60. Kubota T, Khalil AK, Honda M, Ito S, Nishioka Y, Inomata H. Comparative study of retinal nerve fiber layer damage in Japanese patients with normal- and high-tension glaucoma. J Glaucoma. 1999;8(6):363-6.
61. Medeiros FA, Dantas NC, Ginguerra MA, Susanna Junior R. Análise da camada de fibras nervosas da retina em portadores de enxaqueca com aura. Arq Bras Oftalmol. 2001;64(5):389-93.
62. Burk RO, Tuulonen A, Airaksinen PJ. Laser scanning tomography of localised nerve fiber layer defects. Br J Ophthalmol. 1998;82(10):1112-7.
63. Barboza WL, Susanna Junior R. Detecção de defeitos localizados na camada de fibras nervosas retinianas pelo Heidelberg Retina Tomograph. Rev Bras Oftalmol. 1998;57(3):195-200.
64. Teesalu P, Tuulonen A, Airaksinen PJ. Optical coherence tomography and localized defects of the retinal nerve fiber layer. Acta Ophthalmol Scand. 2000; 78(1):49-52.
65. Cense B, Chen TC, Park BH, Pierce MC, de Boer JF. In vivo birefringence and thickness measurements of the human retinal nerve fiber layer using polarization-sensitive optical coherence tomography. J Biomed Opt. 2004; 9(1):121-5.
66. Tavares IM, Sakai VN, Takata TT, Melo Jr LAS, Prata Jr JA. Agreement between optical coherence tomography and scanning laser polarimetry measurements of the retinal nerve fiber layer thickness in glaucomatous patients [abstract]. Invest Ophthalmol Vis Sci. [serial on the Internet]. 2005[cited Feb 10];46: E-Abstract 4816. Available from: http://abstracts.iovs.org/cgi/content/abstract/ 46/5/4816?maxtoshow=&HITS=10&hits=10&RESULTFORMAT= 1&author1=tavares&andorexacttitle=and&andorexacttitleabs= and&ando rexactfulltext=and&searchid= 1119655244017_2676&stored_search= &FIRSTINDEX=0&sortspec= relevance&volume=46&resourcetype=1.10& journalcode=iovsmtg
67. Ajdelsztajn T, Tavares IM, Mello PA, Tanimoto S, Lottemberg CL, Paranhos Jr A. IOP fluctuation effects on scanning laser polarimetry with variable corneal compensator, optical coherence tomography and confocal scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci [serial on the Internet]. 2004 [cited Mar 19];45: E-Abstract 3337. Available from: http://abstracts. iovs.org/cgi/content/abstract/45/53337?maxtoshow=&HITS=10&hits=10& RESULTFORMAT=1&author1=tavares&andorexacttitle=and&andorexactti tleabs=and&andorexactfulltext=and&searchid=1119655355686_2682& stored_ search=&FIRSTINDEX=0&sortspec=relevance&volume= 45&resourcetype =1,10&journalcode=iovsmtg
68. Mello PA, Fasolo LR, Tavares IM, Melo LAS, Jr, Paranhos A, Jr, Prata JA, Jr Sensitivity and specificity of CSLO, SLP, FDT and SWAP in primary open-angle glaucoma: univariate and multivariate analyses. [abstract] Invest Ophthalmol Vis Sci. [serial on the Internet]. 2004 [cited 2005 Jan 12];45: E-Abstract 5528. Available from: http://abstracts.iovs.org/cgi/content/abstract/5/5/5528? maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&author1= fasolo&andorexacttitle=and&andorexacttitleabs=and& andorexactfulltext= and&searchid=1119654846633_2664&stored_search= &FIRSTINDEX=0& sortspec=relevance&volume=45&resourcetype=1, 10&journalcode=iovsmtg
69. Zangwill LM, Bowd C, Berry CC, Williams J, Blumenthal EZ, Sanchez-Galeana CA, et al. Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph. Arch Ophthalmol. 2001;119(7):985-93.
70. Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol. 1984;97(6):730-7.
71. Johnson CA, Brandt JD, Khong AM, Adams AJ. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results. Arch Ophthalmol. 1995;113(1):70-6.
72. Delgado MF, Nguyen NT, Cox TA, Singh K, Lee DA, Ducker DK, et al. Automated perimetry: a report by the American Academy of Ophthalmology. Ophthalmology. 2002;109(12):2362-74.
73. Prata TS, Pires LA, Frizon L, Magosso L, Paranhos A, Jr, Mello PA. Lack of influence of spherical correction in high ametropias on concordance of frequency doubling technology exams [abstract]. Invest Ophthalmol Vis Sci [serial on the Internet]. 2004[cited 2005 Apr 28];45: E-Abstract 3301. Available from: http://abstracts.iovs.org/cgi/content/abstract/45/5/3301?maxto show=&HITS=10&hits=10&RESULTFORMAT=1&author1=frizon& andorexacttitle=and&andorexacttitleabs=and&andorexactfulltext=and& searchid=1119655492281_2685&stored_search=&FIRSTINDEX=0&sortspec =relevance&volume=45&resourcetype=1,10&journalcode=iovsmtg
74. Medeiros FA, Sample PA, Weinreb RN. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol. 2004;137(5):863-71.
75. Iihama DM, Aoki MM, Melo Jr LAS, Tavares IM, Paranhos Jr A. Comparison of visual field defects using different perimetries in glaucomatous patients [abstract]. Invest Ophthalmol Vis Sci [serial on the Internet] 2005 [cited 2005 Jan 27];46: E-Abstract 3726. Available from: http://abstracts. iovs.org/cgi/content/abstract/46/5/3726?maxtoshow=&HITS=10&hits=10& RESULTFORMAT=1&author1=aoki&andorexacttitle=and&andorexactti tleabs=and&andorexactfulltext=and&searchid=1119655594508_2691& stored_search=&FIRSTINDEX=0&sortspec=relevance&volume=46& resourcetype=1,10&journalcode=iovsmtg
76. Landers J, Sharma A, Goldberg I, Graham S. A comparison of perimetric results with the Medmont and Humphrey perimeters. Br J Ophthalmol. 2003; 87(6):690-4.
77. Erratum in: Br J Ophthalmol. 2003;87(8):1054.
78. Aoki MM, Iihama D, Melo LAS, Jr, Mello PA, Paranhos Jr A. Glaucomatous visual field defect: a comparison between static threshold and flicker perimetries [abstract]. Invest Ophthalmol Vis Sci [serial on the Internet]. 2004 [cited 2005 May 24];45: E-Abstract 3307. Available from: http://abstracts. iovs.org/cgi/content/abstract/45/5/3307?maxtoshow=&HITS=10&hits=10& RESULTFORMAT=1&author1=aoki&andorexacttitle=and&andorexactti tleabs=and&andorexactfulltext=and&searchid=1119655712170_2694& stored_search=&FIRSTINDEX=0&sortspec=relevance&volume=45& resourcetype= 1,10&journalcode=iovsmtg
79. Hood DC, Thienprasiddhi P, Greenstein VC, Winn BJ, Ohri N, Liebmann JM, et al. Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry. Invest Ophthalmol Vis Sci. 2004; 45(2):492-8.
80. Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999;117(1):14-6.
81. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypo-tension in optic nerve head ischemic disorders. Ophthalmologica. 1999; 213(2):76-96.
82. Hayreh SS, Podhajsky P, Zimmerman MB. Beta-blocker eyedrops and nocturnal arterial hypotension. Am J Ophthalmol. 1999;128(3):301-9.
83. Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol. 2004;48(4):380-5.
84. Kaiser HJ, Flammer J. Systemic hypotension: a risk factor for glaucomatous damage? Ophthalmologica. 1991;203(3):105-8.
85. Kaiser HJ, Flammer J, Graf T, Stumpfig D. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 1993;231(12):677-80.
86. Hayreh SS. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol. 1999;10(6):474-82.
87. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol. 1999;43(Suppl 1):S10-6.
88. Meyer JH, Brandi-Dohrn J, Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma. Br J Ophthalmol. 1996;80(10):864-7.
89. Ogata N, Imaizumi M, Kurokawa H, Arichi M, Matsumura M. Optic nerve compression by normal carotid artery in patients with normal tension glaucoma. Br J Ophthalmol. 2005;89(2):174-9.
90. Allanore Y, Parc C, Monnet D, Brezin AP, Kahan A. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis. 2004;63(10):1276-8.
91. Anderson DR, Drance SM, Schulzer M: Collaborative Normal-Tension Glaucoma Study Group. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol. 2003;136(5):820-9.
92. Cantor LB. Factors that predict the benefit of lowering intraocular pressure in normal-tension glaucoma. Am J Ophthalmol. 2003;136(5):920.
93. Mabuchi F, Yamagata Z, Kashiwagi K, Tang S, Iijima H, Tsukahara S. Analysis of myocilin gene mutations in Japanese patients with normal tension glaucoma and primary open-angle glaucoma. Clin Genet. 2001;59(4):263-8.
94. Hoyng PF, Kitazawa Y. Medical treatment of normal tension glaucoma. Surv Ophthalmol. 2002;47 (Suppl 1):S116-24.
95. Moura CR, Mello PAA. Tratamiento quirúrgico de glaucoma. Quito: Nocion; 1999.
96. Tavares IM, Higa FS. Implantes de drenagem para glaucoma. In: Paranhos Jr A, Prata Jr JA, Melo Jr LAS, Mello PAA, editores. Urgências em glaucoma. 2a ed. São Paulo: Lemos; 2005. p. 111-6.
97. Higa FS, Melo Jr LAS, Tavares TM, Tito IR, Mello PAA. Resultados do implante de Susanna em glaucoma refratário. Rev Bras Oftalmol. 2004;63(4): 223-9.
98. Lima VCW, Mello PAA, Prata Jr JA. Ciclofotocoagulação com laser diodo em glaucoma refratário, resultado a longo prazo. Arq Bras Oftalmol. 2003; 66(4):449-52.
99. Costa VP, Kuzniec S, Molnar LJ, Cerri GG, Puech-Leao P, Carvalho CA. Clinical findings and hemodynamic changes associated with severe occlusive carotid artery disease. Ophthalmology. 1997;104(12):1994-2002.
100. Costa VP, Kuzniec S, Molnar LJ, Cerri GG, Puech-Leao P, Carvalho CA. The effects of carotid endarterectomy on the retrobulbar circulation of patients with severe occlusive carotid artery disease. An investigation by color Doppler imaging. Ophthalmology. 1999;106(2):306-10.
101. Costa VP, Harris A, Stefansson E, Flammer J, Krieglstein GK, Orzalesi N, et al. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res. 2003;22(6):769-805.
102. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002; 21(4):359-93.
103. Ritch R. Potential role for Ginkgo biloba extract in the treatment of glaucoma. Med Hypotheses. 2000;54(2):221-35.
104. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110(2):359-62, discussion 362-4.
105. Piltz JR, Bose S, Lanchoney D. The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma. 1998;7(5): 336-42.
106. Yamamoto T, Niwa Y, Kawakami H, Kitazawa Y. The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma. J Glaucoma. 1998;7(5):301-5.
107. Luksch A, Rainer G, Koyuncu D, Ehrlich P, Maca T, Gschwandtner ME, et al. Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. Br J Ophthalmol. 2005;89(1):21-5.
108. Barboza WL, Costa VP, Molnar L, Cerri GG. Efeitos da nimodipina na circulação retrobulbar em glaucoma de pressão normal: análise por Doppler colorido. Arq Bras Oftalmol. 1997;60(2):170-3.
109. Okada Y, Ichikawa M, Ishii K, Hara H. Effects of topically instilled bunazosin hydrochloride and other ocular hypotensive drugs on endothelin-1-induced constriction in rabbit retinal arteries. Jpn J Ophthalmol. 2004;48(5):465-9.
110. Wu KY, Wang HZ, Hong SJ. Inhibition of endothelin-1 and KCL-induced increase of [CA2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells. J Ocul Pharmacol Ther. 2004;20(3):201-9.
111. Harris A, Spaeth GL, Sergott RC, Katz LJ, Cantor LB, Martin BJ. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Am J Ophthalmol. 1995;120(2):168-75.
112. Harris A, Migliardi R, Rechtman E, Cole CN, Yee AB, Garzozi HJ. Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients. Eur J Ophthalmol. 2003;13(1):24-31.
113. Galvão Neto P, Figueiredo CR, Suzuki Júnior ER, Figueiredo BP, Batista WD. Efeito dos beta-bloqueadores na pressão intra-ocular e fluxo sangüíneo ocular pulsátil. Rev Bras Oftalmol. 2003;62(11):833-40.
114. Figueiredo CR, Suzuki Júnior ER, Ribeiro BB, Figueiredo BP, Batista WD, Agostini Netto J. Efeito do Bimatoprost, Latanoprost, Travoprost e Unoprostona na pressão intra-ocular e no fluxo sangüíneo ocular. Rev Bras Oftalmol. 2002;61(12):863-9.
115. Figueiredo CR, Figueiredo BP. Fluxo sangüíneo ocular em hipotensores oculares tópicos: estudo prospectivo. Rev Bras Oftalmol. 2001;60(7):471-6.
116. Stefansson E, Pedersen DB, Jensen PK, la Cour M, Kiilgaard JF, Bang K, et al. Optic nerve oxygenation. Prog Retin Eye Res. 2005;24(3):307-32.
117. Hare W, WoldeMussie E, Lai R, Ton H, Ruiz G, Feldmann B, et al. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol. 2001;45 (Suppl 3):S284-9, discussion S295-6.
118. Lipton SA. Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv Ophthalmol. 2003;48(Suppl 1):S38-46.
119. Wheeler LA, Lai R, Woldemussie E. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. Eur J Ophthalmol. 1999;9(Suppl 1):S17-21.
120. Wheeler L, WoldeMussie E, Lai R. Role of alpha-2 agonists in neuroprotection. Surv Ophthalmol. 2003;48(Suppl 1):S47-51.
121. Mello PAA, Melo Jr LAS. Glaucoma nos nossos dias: revendo conceitos e custos. Rev Bras Oftalmol. 2003;62(9):669-77.
122. Kato A, Sugiyama K, Kono Y, Uchida H, Tomita G, Yamamoto T. [Serial topographic changes at the optic disc in normal-tension glaucoma viewed with scanning laser tomography]. Nippon Ganka Gakkai Zasshi. 2003;107(10):597-601. Japanese.
123. Fasolo LR, Mello PAA, Prata Jr JA. Novos métodos propedêuticos em glaucoma. Rev Bras Oftalmol. 2004;63(3):197-207.
124. Tavares IM, Melo Jr LAS, Prata Jr JA, Paranhos Jr A, Mello PAA. Longitudinal changes in the anatomical and functional glaucoma evaluation tests after trabeculectomy. In: American Academy of Ophthalmology/SEO Joint Meeting; 2004 Oct 23-27; New Orleans, p. 183.
125. Tavares IM. Avaliação das alterações anatômicas e funcionais após a trabeculectomia [tese]. São Paulo: Universidade Federal de São Paulo; 2004.